Olav Bergheim

LoneStar Heart, Inc. develops cardiac restorative therapies for patients with heart failure. The firm functions in collaboration with the Texas Heart Institute, the University of Texas Southwestern Medical Center and a global network of leading clinicians. Its flagship product is Algisyl-LVR, a medical device under clinical development intended to prevent or reverse the progression of advanced heart failure in patients who have an enlarged left ventricle. The company was founded in June 2010 by James T. Willerson, Eric N. Olson and Olav B. Bergheim and is headquartered in Laguna Hills, CA.

Domain Associates LLC (Domain Associates) is a venture capital firm founded in 1985. The firm is headquartered in Princeton, New Jersey.

Part of Baxter International, Inc., Baxter Deutschland GmbH is a German company that changes the lives of millions of people around the world every day. The private company is based in Unterschleißheim, Germany. Baxter's products and therapies are used in hospitals and clinics, from the emergency room to the operating room, from the pharmacy to the intensive care unit, improving the care of patients at home. The company's focus on corporate governance is crucial in today's business environment, where investor and public confidence in the company is no longer based solely on financial performance or products and services. Baxter helps maximize safety, streamline procedures, and establish cost efficiencies throughout the clinic. The company was founded in 1960, and the CEO is Christian Wrabetz.

Volcano Corp. is a privately held medical device company founded in 2001. With over 400 worldwide employees, Volcano is focused on the discovery, development and commercialization of products for the detection and treatment of atherosclerosis and vulnerable plaques in the coronary and peripheral vascular systems. Volcano products include Intravascular Ultrasound (IVUS) systems and catheters, as well as physiology guide wires. With global distribution, VOLCANO is a leading provider of innovative diagnostic and therapy-guiding technologies to the interventional cardiology and peripheral vascular fields.

Orqis Medical Corp. develops medical devices and solutions for heart problems. It develops and sells minimally invasive devices that improve cardiac performance through aortic flow therapy. Its products include the CANCION and EXELERAS systems. The company was founded in 1997 and is headquartered in Lake Forest, CA.

Wallace Enterprises, Inc. develops, manufactures and markets devices for treating peripheral vascular disease and nonvascular obstructions. The company was founded by Thomas J. Fogarty in 1997 and is headquartered in Nashville, TN.

CardioPolymers, Inc. provides novel biocompatible polymer implant therapies to treat cronic heart failures. The company was founded in 2003 and is headquartered in Laguna Hills, CA.

Vessix Vascular, Inc. develops products to treat artery disease. The company was founded in 2003 and is headquartered in Laguna Hills, CA.

Fjord Ventures Inc (Fjord Ventures) is a venture capital firm founded in 2005 by Olav B. Bergheim. The firm is headquartered in Laguna Hills, California.

Cardiovascular Group provides cardiovascular services.

Prelude Corp. provides health related services. It offers new paradigm, predictive DCIS test, precision medicine, and clinical evidence services. The company was founded by Troy Bremer in 2009 and is headquartered in Laguna Hills, CA.

Adagio Medical, Inc. provides medical devices. Its products include catheters, esophageal balloon and console. The firm offers transmural lesions to treat cardiac arrhythmias, including paroxysmal and persistent atrial fibrillation, atrial flutter, and ventricular tachycardia. The company was founded by James Cox and Olav Bergheim in 2011 and is headquartered in Laguna Hills, CA.

Kato Pharmaceuticals, Inc. operates as a bio-pharmaceutical company. The firm engages in the development of therapies for pathologies of the eye. It focuses on disease progression and diabetic retinopathy. The company was founded by Olav B. Bergheim and Terrance S. McGovern and is headquartered in Laguna Hills, CA.

Anaxiom Corp. manufactures surgical and medical instruments. The company is headquartered in Laguna Hills, CA.

Otello Medical, Inc. provides healthcare services. The company is headquartered in Laguna Hills, CA.

YAP Therapeutics, Inc. is a genetic medicine company based in Laguna Hills, CA. YAP Therapeutics' technology platform for regeneration and antifibrosis is rooted in modulation of hippo/yap signaling as well as other related pathways. The genetic medicines under development are designed to unlock the regenerative capacity naturally contained within our DNA. These medicines will be delivered via recombinant viral vectors (like AAV) and next-generation non-viral means. YAP Therapeutics is deploying its technology platform to realize the full potential of regenerative medicine to repair organs and cure severe disease for millions of patients. The company was founded to develop and commercialize genetic medicines that regenerate tissue and repair organs for patients suffering from severe disease. The CEO of the company is Olav B. Bergheim.